DKK1 and prostate cancer: According to the evidence, WNT released from metastatic prostate cancer cells can stimulate osteoblasts and promote tumor growth, while Dickkopf-1 (DKK1), which inhibits WNT signaling, can lead to osteolysis, particularly in the early stages of cancer development.